Next-Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients With Lymphoid Malignancies

PURPOSE: Next-generation sequencing (NGS) identifies potentially targetable alterations by US Food and Drug Administration (FDA)–approved drugs and/or by available experimental agents that may not have otherwise been contemplated. Many targeted drugs have been developed for diverse solid cancers; a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Goodman, Aaron M., Choi, Michael, Wieduwilt, Matthew, Mulroney, Carolyn, Costello, Caitlin, Frampton, Garrett, Miller, Vincent, Kurzrock, Razelle
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5495179/
https://ncbi.nlm.nih.gov/pubmed/28681041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.16.00004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados